Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
( 17 18 17 18 O
Symptomatic 18 29 18 29 O
bacterial 30 39 30 39 B-chronic_disease
and 40 43 40 43 O
fungal 44 50 44 50 B-chronic_disease
infection 51 60 51 60 I-chronic_disease
- 61 62 61 62 O
newly 63 68 63 68 O
diagnosed 69 78 69 78 O
and/or 79 85 79 85 O
requiring 86 95 86 95 O
treatment 96 105 96 105 O
) 105 106 105 106 O

Biopsy 0 6 107 113 B-treatment
- 6 7 113 114 O
proven 7 13 114 120 O
neuroendocrine 14 28 121 135 B-cancer
tumor 29 34 136 141 I-cancer

Contraindications 0 17 142 159 O
to 18 20 160 162 O
arteriography 21 34 163 176 B-allergy_name
and 35 38 177 180 O
selective 39 48 181 190 O
visceral 49 57 191 199 O
catheterization 58 73 200 215 B-allergy_name

Contraindications 0 17 216 233 O
to 18 20 234 236 O
hepatic 21 28 237 244 B-treatment
artery 29 35 245 251 I-treatment
embolization 36 48 252 264 I-treatment

INR 0 3 265 268 B-clinical_variable
≤ 4 5 269 270 O
1.5 6 9 271 274 B-upper_bound

Measurable 0 10 275 285 O
metastasis 11 21 286 296 B-cancer
to 22 24 297 299 I-cancer
liver 25 30 300 305 I-cancer
with 31 35 306 310 O
at 36 38 311 313 O
least 39 44 314 319 O
one 45 48 320 323 B-lower_bound
dimension 49 58 324 333 I-lower_bound
≥ 59 60 334 335 O
1.0 61 64 336 339 B-lower_bound
cm 65 67 340 342 I-lower_bound

Participants 0 12 343 355 O
18 13 15 356 358 B-lower_bound
years 16 21 359 364 I-lower_bound
and 22 25 365 368 O
older 26 31 369 374 O

Patients 0 8 375 383 O
must 9 13 384 388 O
be 14 16 389 391 O
at 17 19 392 394 O
least 20 25 395 400 O
one 26 29 401 404 B-lower_bound
month 30 35 405 410 I-lower_bound
beyond 36 42 411 417 O
prior 43 48 418 423 B-treatment
chemotherapy 49 61 424 436 I-treatment
, 61 62 436 437 O
PRRT 63 67 438 442 B-treatment
, 67 68 442 443 O
ablation 69 77 444 452 B-treatment
or 78 80 453 455 O
surgery 81 88 456 463 B-treatment
, 88 89 463 464 O
and 90 93 465 468 O
have 94 98 469 473 O
recovered 99 108 474 483 O
from 109 113 484 488 O
all 114 117 489 492 O
therapy 118 125 493 500 B-treatment
- 125 126 500 501 I-treatment
associated 126 136 501 511 I-treatment
toxicities 137 147 512 522 I-treatment

Performance 0 11 523 534 B-clinical_variable
status 12 18 535 541 I-clinical_variable
0 19 20 542 543 B-lower_bound
- 20 21 543 544 O
2 21 22 544 545 B-upper_bound
on 23 25 546 548 O
Zubrod 26 32 549 555 B-clinical_variable
/ 32 33 555 556 I-clinical_variable
ECOG 33 37 556 560 I-clinical_variable
Performance 38 49 561 572 I-clinical_variable
Scale 50 55 573 578 I-clinical_variable

Platelet 0 8 579 587 B-clinical_variable
count 9 14 588 593 I-clinical_variable
> 15 16 594 595 O
50 17 19 596 598 B-lower_bound
thousands 20 29 599 608 I-lower_bound
/ 29 30 608 609 I-lower_bound
uL 30 32 609 611 I-lower_bound

Pregnant 0 8 612 620 B-pregnancy

Prior 0 5 621 626 O
hepatic 6 13 627 634 B-treatment
arterial 14 22 635 643 I-treatment
therapy 23 30 644 651 I-treatment

Prior 0 5 652 657 B-treatment
surgical 6 14 658 666 I-treatment
resection 15 24 667 676 I-treatment
or 25 27 677 679 O
ablation 28 36 680 688 B-treatment
of 37 39 689 691 O
liver 40 45 692 697 B-cancer
metastases 46 56 698 708 I-cancer
is 57 59 709 711 O
acceptable 60 70 712 722 O

Serum 0 5 723 728 B-clinical_variable
Bilirubin 6 15 729 738 I-clinical_variable
≤ 16 17 739 740 O
2.0 18 21 741 744 B-upper_bound
mg 22 24 745 747 I-upper_bound
/ 24 25 747 748 I-upper_bound
dL 25 27 748 750 I-upper_bound

Serum 0 5 751 756 B-clinical_variable
albumin 6 13 757 764 I-clinical_variable
≥ 14 15 765 766 O
3.0 16 19 767 770 B-lower_bound
g 20 21 771 772 I-lower_bound
/ 21 22 772 773 I-lower_bound
dL 22 24 773 775 I-lower_bound

Serum 0 5 776 781 B-clinical_variable
creatinine 6 16 782 792 I-clinical_variable
< 17 18 793 794 O
2.0 19 22 795 798 B-upper_bound
mg 23 25 799 801 I-upper_bound
/ 25 26 801 802 I-upper_bound
dL 26 28 802 804 I-upper_bound

There 0 5 805 810 O
must 6 10 811 815 O
be 11 13 816 818 O
no 14 16 819 821 O
plans 17 22 822 827 O
for 23 26 828 831 O
the 27 30 832 835 O
patient 31 38 836 843 O
to 39 41 844 846 O
receive 42 49 847 854 O
other 50 55 855 860 O
concomitant 56 67 861 872 B-treatment
therapy 68 75 873 880 I-treatment
while 76 81 881 886 O
on 82 84 887 889 O
this 85 89 890 894 O
protocol 90 98 895 903 B-treatment
treatment 99 108 904 913 I-treatment
( 109 110 914 915 O
other 110 115 915 920 O
than 116 120 921 925 O
somatostatin 121 133 926 938 O
analogs 134 141 939 946 O
or 142 144 947 949 O
bone 145 149 950 954 O
- 149 150 954 955 O
strengthening 150 163 955 968 O
agents 164 170 969 975 O
) 170 171 975 976 O

Tumor 0 5 977 982 B-cancer
burden 6 12 983 989 O
dominant 13 21 990 998 O
in 22 24 999 1001 O
the 25 28 1002 1005 O
liver 29 34 1006 1011 O

Women 0 5 1012 1017 B-gender
/ 5 6 1017 1018 I-gender
men 6 9 1018 1021 I-gender
of 10 12 1022 1024 O
reproductive 13 25 1025 1037 O
potential 26 35 1038 1047 O
may 36 39 1048 1051 O
not 40 43 1052 1055 O
participate 44 55 1056 1067 O
unless 56 62 1068 1074 O
they 63 67 1075 1079 O
have 68 72 1080 1084 O
agreed 73 79 1085 1091 B-contraception_consent
to 80 82 1092 1094 I-contraception_consent
use 83 86 1095 1098 I-contraception_consent
an 87 89 1099 1101 I-contraception_consent
effective 90 99 1102 1111 I-contraception_consent
contraceptive 100 113 1112 1125 I-contraception_consent
method 114 120 1126 1132 I-contraception_consent

bleeding 0 8 1133 1141 B-chronic_disease
diathesis 9 18 1142 1151 I-chronic_disease
not 19 22 1152 1155 O
correctable 23 34 1156 1167 O
by 35 37 1168 1170 O
usual 38 43 1171 1176 O
forms 44 49 1177 1182 O
of 50 52 1183 1185 O
therapy 53 60 1186 1193 B-treatment

criteria 0 8 1194 1202 O
in 9 11 1203 1205 O
the 12 15 1206 1209 O
liver 16 21 1210 1215 O
OR 22 24 1216 1218 O
baseline 25 33 1219 1227 B-clinical_variable
tumor 34 39 1228 1233 I-clinical_variable
burden 40 46 1234 1240 I-clinical_variable
> 47 48 1241 1242 O
25 48 50 1242 1244 B-lower_bound
% 50 51 1244 1245 I-lower_bound
of 52 54 1246 1248 O
the 55 58 1249 1252 O
liver 59 64 1253 1258 O
volume 65 71 1259 1265 O

hepatic 0 7 1266 1273 B-chronic_disease
encephalopathy 8 22 1274 1288 I-chronic_disease

hepatic 0 7 1289 1296 B-treatment
radiation 8 17 1297 1306 I-treatment
therapy 18 25 1307 1314 I-treatment

intolerance 0 11 1315 1326 O
to 12 14 1327 1329 O
contrast 15 23 1330 1338 B-allergy_name
media 24 29 1339 1344 I-allergy_name

lactating 0 9 1345 1354 O
women 10 15 1355 1360 B-gender
may 16 19 1361 1364 O
not 20 23 1365 1368 O
participate 24 35 1369 1380 O
due 36 39 1381 1384 O
to 40 42 1385 1387 O
the 43 46 1388 1391 O
embryotoxic 47 58 1392 1403 O
effects 59 66 1404 1411 O
of 67 69 1412 1414 O
protocol 70 78 1415 1423 B-treatment
treatment 79 88 1424 1433 I-treatment

liver 0 5 1434 1439 B-cancer
tumor 6 11 1440 1445 I-cancer
burden 12 18 1446 1452 O
less 19 23 1453 1457 O
than 24 28 1458 1462 O
or 29 31 1463 1465 O
equal 32 37 1466 1471 O
to 38 40 1472 1474 O
70 41 43 1475 1477 B-upper_bound
% 43 44 1477 1478 I-upper_bound
of 45 47 1479 1481 O
the 48 51 1482 1485 O
total 52 57 1486 1491 B-clinical_variable
liver 58 63 1492 1497 I-clinical_variable
volume 64 70 1498 1504 I-clinical_variable
by 71 73 1505 1507 O
visual 74 80 1508 1514 O
estimate 81 89 1515 1523 O

morphologically 0 15 1524 1539 B-cancer
progressive 16 27 1540 1551 I-cancer
tumor 28 33 1552 1557 I-cancer
by 34 36 1558 1560 O
RECIST 37 43 1561 1567 O

narcotics 0 9 1568 1577 B-treatment

portal 0 6 1578 1584 B-chronic_disease
hypertension 7 19 1585 1597 I-chronic_disease
with 20 24 1598 1602 O
hepatofugal 25 36 1603 1614 O
flow 37 41 1615 1619 O

portal 0 6 1620 1626 B-chronic_disease
vein 7 11 1627 1631 I-chronic_disease
occlusion 12 21 1632 1641 I-chronic_disease
without 22 29 1642 1649 O
hepatopedal 30 41 1650 1661 O
collateral 42 52 1662 1672 O
flow 53 57 1673 1677 O
demonstrated 58 70 1678 1690 O
by 71 73 1691 1693 O
angiography 74 85 1694 1705 B-treatment

sedatives 0 9 1706 1715 B-treatment

severe 0 6 1716 1722 B-chronic_disease
peripheral 7 17 1723 1733 I-chronic_disease
vascular 18 26 1734 1742 I-chronic_disease
disease 27 34 1743 1750 I-chronic_disease
precluding 35 45 1751 1761 O
catheterization 46 61 1762 1777 B-treatment

transpapillary 0 14 1778 1792 B-treatment
biliary 15 22 1793 1800 I-treatment
stent 23 28 1801 1806 I-treatment

